Currently Viewing:
Currently Reading
Large Review Finds Vitamin D Ineffective in Preventing Fractures, Falls
October 15, 2018 – Allison Inserro
Driver Mutations May Predict Patient Outcomes in Myeloproliferative Neoplasms
October 15, 2018 – Kelly Davio
Three Genetic Types Drive Higher Prevalence of MM in African Americans
October 14, 2018 – Laura Joszt
ACOs Had No Significant Impact on Spending for Patients With Cancer
October 14, 2018 – Laura Joszt
Analysis Estimates Empagliflozin Will Add Years to Life for People With Type 2 Diabetes
October 13, 2018 – Mary Caffrey
Study Examines Impact of Deviating From NCCN Guidelines for Metastatic Breast Cancer
October 13, 2018 – Allison Inserro
Researchers Have Found 3 Genes Linked to Chronic Back Pain
October 12, 2018 – Allison Inserro
FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval
October 12, 2018 – Allison Inserro
Know the Risk: 5 Breast Cancer Risk Factors
October 12, 2018 – Samantha DiGrande

Shared Decision-Making Tool Can Identify Best Treatment Plan for Patients With Severe Asthma

Laura Joszt
New tools from the American College of Chest Physicians' CHEST Foundation, the Allergy & Asthma Network, and the American College of Allergy, Asthma & Immunology can help clinicians and patients to work together to choose the best treatment and increase adherence.
A new tool can be used by clinicians and patients to determine the best treatment for patients with severe asthma. The Shared Decision-Making Tool is the result of a collaboration between the CHEST Foundation—the charitable foundation of the American College of Chest Physicians—the Allergy & Asthma Network, and the American College of Allergy, Asthma & Immunology (ACAAI).

Asthma affects 1 in 12 adults and 1 in 11 children in the United States for a total of 22 million Americans. It affects females more than males (9.7% vs 6.9%) and blacks more than whites (11.6% vs 8.3%) or Hispanics (6.6%), according to 2016 data from the CDC. However, as a subset of Hispanics, Puerto Ricans were more affected, with 14.3% having asthma.

“The tool is a step forward in helping direct the conversation between allergists and their patients with asthma,” allergist Bradley Chipps, MD, president of ACAAI, said in a statement. “Fully informed conversations regarding asthma treatment mean greater asthma control and ultimately increased relief for those suffering with asthma.”

According to the press release, some patients with asthma believe their condition is well controlled, which can be a dangerous misconception. The Shared Decision-Making Tool is supposed to shed light on the importance of self-management, shared decision making, and the importance of knowing the difference between controlled and uncontrolled asthma.

The tool is available online and in print and can help patients and clinicians to work together to choose the best treatment plan and increase adherence.

The partnership has also yielded another tool, which can be used to improve patient awareness and monitor and manage asthma symptoms. The Asthma Severity Assessment Tool can determine if a patient needs to visit an asthma specialist.

“We hope these tools will arm patients with the knowledge needed to talk effectively with doctors about their asthma and empower them to achieve optimal health outcomes,” said Tonya Winders, president and CEO of the Allergy & Asthma Network.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!